Astria Therapeutics Stock Market Value
| ATXS Stock | USD 12.95 0.03 0.23% |
| Symbol | Astria |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astria Therapeutics. If investors know Astria will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astria Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Astria Therapeutics is measured differently than its book value, which is the value of Astria that is recorded on the company's balance sheet. Investors also form their own opinion of Astria Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Astria Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astria Therapeutics' market value can be influenced by many factors that don't directly affect Astria Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astria Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Astria Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astria Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Astria Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Astria Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Astria Therapeutics.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Astria Therapeutics on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Astria Therapeutics or generate 0.0% return on investment in Astria Therapeutics over 30 days. Astria Therapeutics is related to or competes with Erasca, MeiraGTx Holdings, ArriVent BioPharma,, MBX Biosciences,, Valneva SE, Ginkgo Bioworks, and Iovance Biotherapeutics. Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of ... More
Astria Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Astria Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Astria Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.19 | |||
| Information Ratio | 0.1806 | |||
| Maximum Drawdown | 38.97 | |||
| Value At Risk | (1.79) | |||
| Potential Upside | 3.57 |
Astria Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Astria Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Astria Therapeutics' standard deviation. In reality, there are many statistical measures that can use Astria Therapeutics historical prices to predict the future Astria Therapeutics' volatility.| Risk Adjusted Performance | 0.1473 | |||
| Jensen Alpha | 0.8793 | |||
| Total Risk Alpha | 0.4425 | |||
| Sortino Ratio | 0.76 | |||
| Treynor Ratio | 0.7376 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astria Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Astria Therapeutics Backtested Returns
Astria Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Astria Therapeutics secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. By analyzing Astria Therapeutics' technical indicators, you can evaluate if the expected return of 0.99% is justified by implied risk. Please makes use of Astria Therapeutics' Coefficient Of Variation of 505.92, risk adjusted performance of 0.1473, and Mean Deviation of 1.95 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Astria Therapeutics holds a performance score of 15. The firm shows a Beta (market volatility) of 1.33, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astria Therapeutics will likely underperform. Please check Astria Therapeutics' downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to make a quick decision on whether Astria Therapeutics' price patterns will revert.
Auto-correlation | -0.47 |
Modest reverse predictability
Astria Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Astria Therapeutics time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Astria Therapeutics price movement. The serial correlation of -0.47 indicates that about 47.0% of current Astria Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Astria Therapeutics lagged returns against current returns
Autocorrelation, which is Astria Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Astria Therapeutics' stock expected returns. We can calculate the autocorrelation of Astria Therapeutics returns to help us make a trade decision. For example, suppose you find that Astria Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Astria Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Astria Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Astria Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Astria Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Astria Therapeutics Lagged Returns
When evaluating Astria Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Astria Therapeutics stock have on its future price. Astria Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Astria Therapeutics autocorrelation shows the relationship between Astria Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Astria Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Astria Stock Analysis
When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.